Arkolith/Insider Trading/LUNG/Form 4

Radhakrishnan Srikanth

Chief Science &Techn. OfficerPulmonx Corp (LUNG) · full profile →Form 4 · filed Mar 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$15K
Net Open-Market Flow
-$15K
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2026Sell(S)4K$1.43$6K171K
Mar 2, 2026Sell(S)2K$1.43$4K175K
Mar 2, 2026Grant(A)175K—$0346K
Mar 2, 2026Sell(S)756$1.43$1K180K
Mar 2, 2026Sell(S)3K$1.43$4K177K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002098678-26-000001) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML